Us Congress 2025-2026 Regular Session

Us Congress House Bill HB307 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	I
2	2	119THCONGRESS
3	3	1
4	4	STSESSION H. R. 307
5	5	To amend titles XVIII and XIX of the Social Security Act to provide for
6	6	coverage of peripheral artery disease screening tests furnished to at-
7	7	risk beneficiaries under the Medicare and Medicaid programs without
8	8	the imposition of cost-sharing requirements, and for other purposes.
9	9	IN THE HOUSE OF REPRESENTATIVES
10	10	JANUARY9, 2025
11	11	Mrs. M
12	12	CIVER(for herself, Mr. JACKSONof Illinois, and Ms. KELLYof Illinois)
13	13	introduced the following bill; which was referred to the Committee on En-
14	14	ergy and Commerce, and in addition to the Committee on Ways and
15	15	Means, for a period to be subsequently determined by the Speaker, in
16	16	each case for consideration of such provisions as fall within the jurisdic-
17	17	tion of the committee concerned
18	18	A BILL
19	19	To amend titles XVIII and XIX of the Social Security Act
20	20	to provide for coverage of peripheral artery disease
21	21	screening tests furnished to at-risk beneficiaries under
22	22	the Medicare and Medicaid programs without the imposi-
23	23	tion of cost-sharing requirements, and for other pur-
24	24	poses.
25	25	Be it enacted by the Senate and House of Representa-1
26	26	tives of the United States of America in Congress assembled, 2
27	27	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
28	28	ssavage on LAPJG3WLY3PROD with BILLS 2
29	29	•HR 307 IH
30	30	SECTION 1. SHORT TITLE; FINDINGS. 1
31	31	(a) S
32	32	HORTTITLE.—This Act may be cited as the 2
33	33	‘‘Amputation Reduction and Compassion Act of 2025’’ or 3
34	34	the ‘‘ARC Act of 2025’’. 4
35	35	(b) F
36	36	INDINGS.—Congress makes the following find-5
37	37	ings: 6
38	38	(1) Atherosclerosis occurs when blood flow is 7
39	39	reduced because arteries become narrowed or 8
40	40	blocked with fatty deposits. 9
41	41	(2) Atherosclerosis is responsible for more 10
42	42	deaths in the United States than any other condi-11
43	43	tion, and heart attacks, resulting from clogged coro-12
44	44	nary arteries, are the leading cause of death in 13
45	45	America. 14
46	46	(3) Atherosclerosis also occurs in the legs and 15
47	47	is known as peripheral artery disease (in this sub-16
48	48	section referred to as ‘‘PAD’’) and having PAD sig-17
49	49	nificantly increases the risk for heart attack, stroke, 18
50	50	amputation, and death. 19
51	51	(4) While most Americans are aware of athero-20
52	52	sclerosis in the heart, many Americans have never 21
53	53	heard of PAD and Americans with PAD are often 22
54	54	unaware of the serious risks of the disease. 23
55	55	(5) An estimated 21 million Americans have 24
56	56	PAD, and about 200,000 of them—disproportion-25
57	57	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
58	58	ssavage on LAPJG3WLY3PROD with BILLS 3
59	59	•HR 307 IH
60	60	ately minorities—suffer avoidable amputations every 1
61	61	year as a result of such disease. 2
62	62	(6) According to the Dartmouth Atlas, amputa-3
63	63	tion risks for African Americans living with diabetes 4
64	64	are as much as four times higher than the national 5
65	65	average. 6
66	66	(7) Data analyses have similarly found that Na-7
67	67	tive Americans are more than twice as likely to be 8
68	68	subjected to amputation and Hispanics are up to 75 9
69	69	percent more likely to have an amputation. 10
70	70	(8) Fifty-two percent of patients with an above- 11
71	71	the-knee amputation and 33 percent of patients with 12
72	72	a below-the-knee amputation will die within two 13
73	73	years of their amputation. 14
74	74	(9) Screening and arterial testing for PAD is 15
75	75	cost-effective and should be part of routine medical 16
76	76	care. 17
77	77	(10) Once PAD is detected, amputations and 18
78	78	deaths can be reduced through the use of national, 19
79	79	evidence-based PAD care guidelines. 20
80	80	(11) Americans with a PAD diagnosis are asso-21
81	81	ciated with a 67-percent increase in the risk of car-22
82	82	diac death compared to people without a PAD diag-23
83	83	nosis. Consequently, screening for PAD enables 24
84	84	health care professionals to identify cardiac risk fac-25
85	85	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
86	86	ssavage on LAPJG3WLY3PROD with BILLS 4
87	87	•HR 307 IH
88	88	tors earlier and take proactive measures to reduce 1
89	89	the risk of cardiac death. 2
90	90	SEC. 2. PERIPHERAL ARTERY DISEASE EDUCATION PRO-3
91	91	GRAM. 4
92	92	Part P of title III of the Public Health Service Act 5
93	93	(42 U.S.C. 280g et seq.) is amended by adding at the end 6
94	94	the following new section: 7
95	95	‘‘SEC. 399V–8. PERIPHERAL ARTERY DISEASE EDUCATION 8
96	96	PROGRAM. 9
97	97	‘‘(a) E
98	98	STABLISHMENT.—The Secretary, acting 10
99	99	through the Director of the Centers for Disease Control 11
100	100	and Prevention, in collaboration with the Administrator 12
101	101	of the Centers for Medicare & Medicaid Services, the Ad-13
102	102	ministrator of the Health Resources and Services Admin-14
103	103	istration, leading clinical and patient advocacy organiza-15
104	104	tions, and other interested stakeholders shall establish and 16
105	105	coordinate a peripheral artery disease education program 17
106	106	to support, develop, and implement educational initiatives 18
107	107	and outreach strategies that inform health care profes-19
108	108	sionals and the public about the existence of peripheral 20
109	109	artery disease and methods to reduce amputations related 21
110	110	to such disease, particularly with respect to at-risk popu-22
111	111	lations. 23
112	112	‘‘(b) B
113	113	ESTPRACTICES.—The Secretary shall, as ap-24
114	114	propriate, identify and disseminate to health care profes-25
115	115	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
116	116	ssavage on LAPJG3WLY3PROD with BILLS 5
117	117	•HR 307 IH
118	118	sionals best practices with respect to peripheral artery dis-1
119	119	ease. 2
120	120	‘‘(c) A
121	121	UTHORIZATION OF APPROPRIATIONS.—There 3
122	122	is authorized to be appropriated to carry out this section 4
123	123	$6,000,000 for each of fiscal years 2026 through 2030.’’. 5
124	124	SEC. 3. MEDICARE COVERAGE OF PERIPHERAL ARTERY 6
125	125	DISEASE SCREENING TESTS FURNISHED TO 7
126	126	AT-RISK BENEFICIARIES WITHOUT IMPOSI-8
127	127	TION OF COST-SHARING REQUIREMENTS. 9
128	128	(a) I
129	129	NGENERAL.—Section 1861 of the Social Secu-10
130	130	rity Act (42 U.S.C. 1395x) is amended— 11
131	131	(1) in subsection (s)(2)— 12
132	132	(A) in subparagraph (JJ), by striking the 13
133	133	semicolon at the end and inserting ‘‘; and’’; and 14
134	134	(B) by adding at the end the following new 15
135	135	subparagraph: 16
136	136	‘‘(KK) peripheral artery disease screening tests 17
137	137	furnished to at-risk beneficiaries (as such terms are 18
138	138	defined in subsection (nnn)).’’; and 19
139	139	(2) by adding at the end the following new sub-20
140	140	section: 21
141	141	‘‘(nnn) P
142	142	ERIPHERALARTERYDISEASESCREENING 22
143	143	T
144	144	EST; AT-RISKBENEFICIARY.—(1) The term ‘peripheral 23
145	145	artery disease screening test’ means— 24
146	146	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
147	147	ssavage on LAPJG3WLY3PROD with BILLS 6
148	148	•HR 307 IH
149	149	‘‘(A) noninvasive physiologic studies of extrem-1
150	150	ity arteries (commonly referred to as ankle-brachial 2
151	151	index testing); 3
152	152	‘‘(B) arterial duplex scans of lower extremity 4
153	153	arteries vascular; and 5
154	154	‘‘(C) such other items and services as the Sec-6
155	155	retary determines, in consultation with relevant 7
156	156	stakeholders, to be appropriate for screening for pe-8
157	157	ripheral artery disease for at-risk beneficiaries. 9
158	158	‘‘(2) The term ‘at-risk beneficiary’ means an indi-10
159	159	vidual entitled to, or enrolled for, benefits under part A 11
160	160	and enrolled for benefits under part B— 12
161	161	‘‘(A) who is 65 years of age or older; 13
162	162	‘‘(B) who is at least 50 years of age but not 14
163	163	older than 64 years of age with risk factors for ath-15
164	164	erosclerosis (such as diabetes mellitus, a history of 16
165	165	smoking, hyperlipidemia, and hypertension) or a 17
166	166	family history of peripheral artery disease; 18
167	167	‘‘(C) who is younger than 50 years of age with 19
168	168	diabetes mellitus and one additional risk factor for 20
169	169	atherosclerosis; or 21
170	170	‘‘(D) with a known atherosclerotic disease in 22
171	171	another vascular bed such as coronary, carotid, sub-23
172	172	clavian, renal, or mesenteric artery stenosis, or ab-24
173	173	dominal aortic aneurysm. 25
174	174	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
175	175	ssavage on LAPJG3WLY3PROD with BILLS 7
176	176	•HR 307 IH
177	177	‘‘(3) The Secretary shall, in consultation with appro-1
178	178	priate organizations, establish standards regarding the 2
179	179	frequency for peripheral artery disease screening tests de-3
180	180	scribed in subsection (s)(2)(KK) for purposes of coverage 4
181	181	under this title.’’. 5
182	182	(b) I
183	183	NCLUSION OFPERIPHERALARTERYDISEASE 6
184	184	S
185	185	CREENINGTESTS ININITIALPREVENTIVEPHYSICAL 7
186	186	E
187	187	XAMINATION.—Section 1861(ww)(2) of the Social Secu-8
188	188	rity Act (42 U.S.C. 1395x(ww)(2)) is amended— 9
189	189	(1) in subparagraph (N), by moving the mar-10
190	190	gins of such subparagraph 2 ems to the left; 11
191	191	(2) by redesignating subparagraph (O) as sub-12
192	192	paragraph (P); and 13
193	193	(3) by inserting after subparagraph (N) the fol-14
194	194	lowing new subparagraph: 15
195	195	‘‘(O) Peripheral artery disease screening tests 16
196	196	furnished to at risk-beneficiaries (as such terms are 17
197	197	defined in subsection (nnn)).’’. 18
198	198	(c) P
199	199	AYMENT.— 19
200	200	(1) I
201	201	N GENERAL.—Section 1833(a) of the So-20
202	202	cial Security Act (42 U.S.C. 1395l(a)) is amended— 21
203	203	(A) in paragraph (1)— 22
204	204	(i) in subparagraph (N), by inserting 23
205	205	‘‘and other than peripheral artery disease 24
206	206	screening tests furnished to at-risk bene-25
207	207	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
208	208	ssavage on LAPJG3WLY3PROD with BILLS 8
209	209	•HR 307 IH
210	210	ficiaries (as such terms are defined in sec-1
211	211	tion 1861(nnn))’’ after ‘‘other than person-2
212	212	alized prevention plan services (as defined 3
213	213	in section 1861(hhh)(1))’’; 4
214	214	(ii) by striking ‘‘and’’ before ‘‘(HH)’’; 5
215	215	and 6
216	216	(iii) by adding at the end the fol-7
217	217	lowing: ‘‘and (II) with respect to peripheral 8
218	218	artery disease screening tests furnished to 9
219	219	at-risk beneficiaries (as such terms are de-10
220	220	fined in section 1861(nnn)), the amount 11
221	221	paid shall be 100 percent of the lesser of 12
222	222	the actual charge for the services or the 13
223	223	amount determined under the payment 14
224	224	basis determined under section 1848;’’; 15
225	225	and 16
226	226	(B) in paragraph (2)— 17
227	227	(i) in subparagraph (G), by striking 18
228	228	‘‘and’’ at the end; 19
229	229	(ii) in subparagraph (H), by striking 20
230	230	the semicolon at the end and inserting ‘‘; 21
231	231	and’’; and 22
232	232	(iii) by inserting after subparagraph 23
233	233	(H) the following new subparagraph: 24
234	234	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
235	235	ssavage on LAPJG3WLY3PROD with BILLS 9
236	236	•HR 307 IH
237	237	‘‘(I) with respect to peripheral artery disease 1
238	238	screening tests (as defined in paragraph (1) of sec-2
239	239	tion 1861(nnn)) furnished by an outpatient depart-3
240	240	ment of a hospital to at-risk beneficiaries (as defined 4
241	241	in paragraph (2) of such section), the amount deter-5
242	242	mined under paragraph (1)(II);’’. 6
243	243	(2) N
244	244	O DEDUCTIBLE.—Section 1833(b) of the 7
245	245	Social Security Act (42 U.S.C. 1395l(b)) is amend-8
246	246	ed, in the first sentence— 9
247	247	(A) by striking ‘‘, and’’ before ‘‘(13)’’; and 10
248	248	(B) by inserting before the period at the 11
249	249	end the following: ‘‘, and (14) such deductible 12
250	250	shall not apply with respect to peripheral artery 13
251	251	disease screening tests furnished to at-risk 14
252	252	beneficiaries (as such terms are defined in sec-15
253	253	tion 1861(nnn))’’. 16
254	254	(3) E
255	255	XCLUSION FROM PROSPECTIVE PAYMENT 17
256	256	SYSTEM FOR HOSPITAL OUTPATIENT DEPARTMENT 18
257	257	SERVICES.—Section 1833(t)(1)(B)(iv) of the Social 19
258	258	Security Act (42 U.S.C. 1395l(t)(1)(B)(iv)) is 20
259	259	amended— 21
260	260	(A) by striking ‘‘, or personalized’’ and in-22
261	261	serting ‘‘, personalized’’; and 23
262	262	(B) by inserting ‘‘, or peripheral artery 24
263	263	disease screening tests furnished to at-risk 25
264	264	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00009 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
265	265	ssavage on LAPJG3WLY3PROD with BILLS 10
266	266	•HR 307 IH
267	267	beneficiaries (as such terms are defined in sec-1
268	268	tion 1861(nnn))’’ after ‘‘personalized prevention 2
269	269	plan services (as defined in section 3
270	270	1861(hhh)(1))’’. 4
271	271	(4) C
272	272	ONFORMING AMENDMENT .—Section 5
273	273	1848(j)(3) of the Social Security Act (42 U.S.C. 6
274	274	1395w–4(j)(3)) is amended by striking ‘‘(2)(FF) 7
275	275	(including administration of the health risk assess-8
276	276	ment),’’ and inserting ‘‘(2)(FF) (including adminis-9
277	277	tration of the health risk assessment), (2)(KK),’’. 10
278	278	(d) E
279	279	XCLUSIONFROMCOVERAGE ANDMEDICARE AS 11
280	280	S
281	281	ECONDARYPAYER FORTESTSPERFORMEDMOREFRE-12
282	282	QUENTLYTHANALLOWED.—Section 1862(a)(1) of the 13
283	283	Social Security Act (42 U.S.C. 1395y(a)(1)) is amended— 14
284	284	(1) in subparagraph (O), by striking ‘‘and’’ at 15
285	285	the end; 16
286	286	(2) in subparagraph (P), by striking the semi-17
287	287	colon at the end and inserting ‘‘, and’’; and 18
288	288	(3) by adding at the end the following new sub-19
289	289	paragraph: 20
290	290	‘‘(Q) in the case of peripheral artery disease 21
291	291	screening tests furnished to at-risk beneficiaries (as 22
292	292	such terms are defined in section 1861(nnn)), which 23
293	293	are performed more frequently than is covered under 24
294	294	such section;’’. 25
295	295	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00010 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
296	296	ssavage on LAPJG3WLY3PROD with BILLS 11
297	297	•HR 307 IH
298	298	(e) AUTHORITYTOMODIFY ORELIMINATECOV-1
299	299	ERAGE OF CERTAINPREVENTIVESERVICES.—Section 2
300	300	1834(n) of the Social Security Act (42 U.S.C. 1395m(n)) 3
301	301	is amended— 4
302	302	(1) by redesignating subparagraphs (A) and 5
303	303	(B) of paragraph (1) as clauses (i) and (ii), respec-6
304	304	tively, and moving the margins of such clauses, as 7
305	305	so redesignated, 2 ems to the right; 8
306	306	(2) by redesignating paragraphs (1) and (2) as 9
307	307	subparagraphs (A) and (B), respectively, and mov-10
308	308	ing the margins of such subparagraphs, as so redes-11
309	309	ignated, 2 ems to the right; 12
310	310	(3) by striking ‘‘C
311	311	ERTAINPREVENTIVESERV-13
312	312	ICES’’ and all that follows through ‘‘any other provi-14
313	313	sion of this title’’ and inserting: ‘‘C
314	314	ERTAINPREVEN-15
315	315	TIVESERVICES.— 16
316	316	‘‘(1) I
317	317	N GENERAL.—Notwithstanding any other 17
318	318	provision of this title’’; and 18
319	319	(4) by adding at the end the following new 19
320	320	paragraph: 20
321	321	‘‘(2) I
322	322	NAPPLICABILITY.—The Secretarial au-21
323	323	thority described in paragraph (1) shall not apply 22
324	324	with respect to preventive services described in sec-23
325	325	tion 1861(ww)(2)(O).’’. 24
326	326	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00011 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
327	327	ssavage on LAPJG3WLY3PROD with BILLS 12
328	328	•HR 307 IH
329	329	(f) EFFECTIVEDATE.—The amendments made by 1
330	330	this section shall apply with respect to items and services 2
331	331	furnished on or after January 1, 2026. 3
332	332	SEC. 4. MEDICAID COVERAGE OF PERIPHERAL ARTERY 4
333	333	DISEASE SCREENING TESTS FURNISHED TO 5
334	334	AT-RISK BENEFICIARIES WITHOUT IMPOSI-6
335	335	TION OF COST-SHARING REQUIREMENTS. 7
336	336	(a) I
337	337	NGENERAL.—Section 1905 of the Social Secu-8
338	338	rity Act (42 U.S.C. 1396d) is amended— 9
339	339	(1) in subsection (a)— 10
340	340	(A) in paragraph (31), by striking ‘‘and’’ 11
341	341	at the end; 12
342	342	(B) by redesignating paragraph (32) as 13
343	343	paragraph (33); and 14
344	344	(C) by inserting after paragraph (31) the 15
345	345	following new paragraph: 16
346	346	‘‘(32) peripheral artery disease screening tests 17
347	347	furnished to at-risk beneficiaries (as such terms are 18
348	348	defined in subsection (kk)); and’’; and 19
349	349	(2) by adding at the end the following new sub-20
350	350	section: 21
351	351	‘‘(kk) P
352	352	ERIPHERALARTERYDISEASESCREENING 22
353	353	T
354	354	EST; AT-RISKBENEFICIARY.— 23
355	355	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00012 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
356	356	ssavage on LAPJG3WLY3PROD with BILLS 13
357	357	•HR 307 IH
358	358	‘‘(1) PERIPHERAL ARTERY DISEASE SCREENING 1
359	359	TEST.—The term ‘peripheral artery disease screen-2
360	360	ing test’ means— 3
361	361	‘‘(A) noninvasive physiologic studies of ex-4
362	362	tremity arteries (commonly referred to as ankle- 5
363	363	brachial index testing); 6
364	364	‘‘(B) arterial duplex scans of lower extrem-7
365	365	ity arteries vascular; and 8
366	366	‘‘(C) such other items and services as the 9
367	367	Secretary determines, in consultation with rel-10
368	368	evant stakeholders, to be appropriate for 11
369	369	screening for peripheral artery disease for at- 12
370	370	risk beneficiaries. 13
371	371	‘‘(2) A
372	372	T-RISK BENEFICIARY.—The term ‘at-risk 14
373	373	beneficiary’ means an individual enrolled under a 15
374	374	State plan (or a waiver of such plan)— 16
375	375	‘‘(A) who is 65 years of age or older; 17
376	376	‘‘(B) who is at least 50 years of age but 18
377	377	not older than 64 years of age with risk factors 19
378	378	for atherosclerosis (such as diabetes mellitus, a 20
379	379	history of smoking, hyperlipidemia, and hyper-21
380	380	tension) or a family history of peripheral artery 22
381	381	disease; 23
382	382	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00013 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
383	383	ssavage on LAPJG3WLY3PROD with BILLS 14
384	384	•HR 307 IH
385	385	‘‘(C) who is younger than 50 years of age 1
386	386	with diabetes mellitus and one additional risk 2
387	387	factor for atherosclerosis; or 3
388	388	‘‘(D) with a known atherosclerotic disease 4
389	389	in another vascular bed such as coronary, ca-5
390	390	rotid, subclavian, renal, or mesenteric artery 6
391	391	stenosis, or abdominal aortic aneurysm. 7
392	392	‘‘(3) F
393	393	REQUENCY.—The Secretary shall, in con-8
394	394	sultation with appropriate organizations, establish 9
395	395	standards regarding the frequency for peripheral ar-10
396	396	tery disease screening tests described in subsection 11
397	397	(a)(31) for purposes of coverage under a State plan 12
398	398	under this title.’’. 13
399	399	(b) N
400	400	OCOSTSHARING.— 14
401	401	(1) I
402	402	N GENERAL.—Subsections (a)(2) and 15
403	403	(b)(2) of section 1916 of the Social Security Act (42 16
404	404	U.S.C. 1396o) are each amended— 17
405	405	(A) in subparagraph (I), by striking ‘‘or’’ 18
406	406	at the end; 19
407	407	(B) in subparagraph (J), by striking ‘‘; 20
408	408	and’’ and inserting ‘‘, or’’; and 21
409	409	(C) by adding at the end the following new 22
410	410	subparagraph: 23
411	411	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00014 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
412	412	ssavage on LAPJG3WLY3PROD with BILLS 15
413	413	•HR 307 IH
414	414	‘‘(K) peripheral artery disease screening 1
415	415	tests furnished to at-risk beneficiaries (as such 2
416	416	terms are defined in section 1905(kk)); and’’. 3
417	417	(2) A
418	418	PPLICATION TO ALTERNATIVE COST SHAR -4
419	419	ING.—Section 1916A(b)(3)(B) of the Social Security 5
420	420	Act (42 U.S.C. 1396o–1(b)(3)(B)) is amended by 6
421	421	adding at the end the following new clause: 7
422	422	‘‘(xv) Peripheral artery disease screen-8
423	423	ing tests furnished to at-risk beneficiaries 9
424	424	(as such terms are defined in section 10
425	425	1905(kk)).’’. 11
426	426	(c) C
427	427	ONFORMINGAMENDMENTS.— 12
428	428	(1) Section 1902(nn)(3) of the Social Security 13
429	429	Act (42 U.S.C. 1396a(nn)(3)) is amended by strik-14
430	430	ing ‘‘following paragraph (31)’’ and inserting ‘‘fol-15
431	431	lowing paragraph (32)’’. 16
432	432	(2) Section 1905(a) of the Social Security Act 17
433	433	(42 U.S.C. 1396d(a)) is amended by striking ‘‘fol-18
434	434	lowing paragraph (31)’’ and inserting ‘‘following 19
435	435	paragraph (32)’’. 20
436	436	SEC. 5. DEVELOPMENT AND IMPLEMENTATION OF QUALITY 21
437	437	MEASURES. 22
438	438	(a) D
439	439	EVELOPMENT.—The Secretary of Health and 23
440	440	Human Services (referred to in this section as the ‘‘Sec-24
441	441	retary’’) shall, in consultation with relevant stakeholders, 25
442	442	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00015 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
443	443	ssavage on LAPJG3WLY3PROD with BILLS 16
444	444	•HR 307 IH
445	445	develop quality measures for nontraumatic, lower-limb, 1
446	446	major amputation that utilize appropriate diagnostic 2
447	447	screening (including peripheral artery disease screening) 3
448	448	in order to encourage alternative treatments (including 4
449	449	revascularization) in lieu of such an amputation. 5
450	450	(b) I
451	451	MPLEMENTATION.—Not later than 18 months 6
452	452	after the date of enactment of this Act, the Secretary shall 7
453	453	complete appropriate testing and validation of the meas-8
454	454	ures developed under subsection (a) and shall incorporate 9
455	455	such measures in quality reporting programs for appro-10
456	456	priate providers of services and suppliers under the Medi-11
457	457	care program under title XVIII of the Social Security Act 12
458	458	(42 U.S.C. 1395 et seq.), including for purposes of— 13
459	459	(1) the merit-based incentive payment system 14
460	460	under section 1848(q) of such Act (42 U.S.C. 15
461	461	1395w–4(q)); 16
462	462	(2) incentive payments for participation in eligi-17
463	463	ble alternative payment models under section 18
464	464	1833(z) of such Act (42 U.S.C. 1395l(z)); 19
465	465	(3) the shared savings program under section 20
466	466	1899 of such Act (42 U.S.C. 1395jjj); 21
467	467	(4) models under section 1115A of such Act 22
468	468	(42 U.S.C. 1315a); and 23
469	469	(5) such other payment systems or models as 24
470	470	the Secretary may specify. 25
471	471	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00016 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
472	472	ssavage on LAPJG3WLY3PROD with BILLS 17
473	473	•HR 307 IH
474	474	SEC. 6. AMPUTATION PREVENTION PILOT PROGRAM. 1
475	475	(a) I
476	476	NGENERAL.—Section 1115A(b)(2)(B) of the 2
477	477	Social Security Act (42 U.S.C. 1315a(b)(2)(B)) is amend-3
478	478	ed by adding at the end the following new clause: 4
479	479	‘‘(xxviii) Promoting voluntary, non-5
480	480	traumatic lower-limb major amputation 6
481	481	prevention programs at hospitals, ambula-7
482	482	tory surgical centers, and office-based cen-8
483	483	ters that will increase access to amputation 9
484	484	prevention services, reduce amputation 10
485	485	rates, and reduce costs to such hospitals, 11
486	486	surgical centers, and office-based centers, 12
487	487	through— 13
488	488	‘‘(I) patient risk modification and 14
489	489	management; 15
490	490	‘‘(II) early screening and detec-16
491	491	tion and surveillance; 17
492	492	‘‘(III) testing and treatment for 18
493	493	peripheral artery disease; and 19
494	494	‘‘(IV) improved care coordination 20
495	495	for individuals at high risk for ampu-21
496	496	tation.’’. 22
497	497	(b) T
498	498	ESTING OFMODEL.—Not later than 18 months 23
499	499	after the date of the enactment of this Act, the Deputy 24
500	500	Administrator and Director of the Center for Medicare 25
501	501	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00017 Fmt 6652 Sfmt 6201 E:\BILLS\H307.IH H307
502	502	ssavage on LAPJG3WLY3PROD with BILLS 18
503	503	•HR 307 IH
504	504	and Medicaid Innovation shall test the model described 1
505	505	under subsection (a). 2
506	506	Æ
507	507	VerDate Sep 11 2014 22:04 Feb 05, 2025 Jkt 059200 PO 00000 Frm 00018 Fmt 6652 Sfmt 6301 E:\BILLS\H307.IH H307
508	508	ssavage on LAPJG3WLY3PROD with BILLS